Bisphosphonates use reduces breast cancer risk?
Another study identifies the risk reduction of breast cancer development in women using bisphosphonates for osteoporosis.
Its getting even more frequent the “incidental” finding of cancer risk reduction in studies using non steroid anti-inflammatory agents, bisphosphonates and statins. These findings are relevant clues about the role of inflammation and cancer development. There is a growing evidence that inflammation is pivotal in cancinogenesis… it´s the second post about it this week.
Follow the link from BJC: : http://ow.ly/1A0ed
Sunday, April 18, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment